Investor Presentaiton slide image

Investor Presentaiton

Novo Nordisk Annual Report 2023 Introducing Novo Nordisk Strategic Aspirations Risks Management Consolidated statements Additional information 65 59 3.4 Trade receivables Movements in allowance for doubtful trade receivables Gross carrying DKK million 2023 Not yet due 1-90 days 91-180 days Loss amount allowance Net carrying DKK million Carrying amount at the beginning of the year 2023 1,520 2022 1,430 amount Reversal of allowance on realised losses (39) (15) 64,327 1,557 (1,095) 63,232 Net movement recognised in income statement Effect of exchange rate adjustment 413 212 (100) (107) (160) 1,397 Allowance at the end of the year 1,794 1,520 211 (100) 111 181-270 days 111 (81) 30 271-360 days 90 (90) More than 360 days past due 268 (268) Trade receivables 66,564 (1,794) EMEA 10,183 China 1,865 (859) (9) Rest of World 6,396 (843) 64,770 9,324 1,856 5,553 North America Operations 48,120 (83) 48,037 Novo Nordisk's customer base is comprised of government agencies, wholesalers, retail pharmacies and other customers. Novo Nordisk closely monitors the current economic conditions of countries impacted by currency fluctuations, high inflation and an unstable political climate. These indicators, as well as payment history, are taken into account in the valuation of trade receivables. Overall, the country risk ratings in 2023 have remained unchanged from 2022. No loss allowance has been recognised on trade receivables in factoring portfolios in 2023 and 2022. Refer to note 4.4 for more information on the trade receivable programmes. ACCOUNTING POLICIES Trade receivables are initially recognised at transaction price and subsequently measured at amortised cost using the effective interest method, less allowance for doubtful trade receivables. The split of trade receivables and allowance for trade receivables is based on the location of the customer. Before being sold, trade receivables in factoring portfolios are measured at fair value with changes recognised in other comprehensive income. The allowance for doubtful receivables is deducted from the carrying amount of trade receivables, and the amount of the loss is recognised in the income statement under sales and distribution costs. Subsequent recoveries of amounts previously written off are credited against sales and distribution costs. Management makes allowance for doubtful trade receivables based on the simplified approach to provide for expected credit losses, which requires the use of the lifetime expected loss provision for all trade receivables. The allowance is an estimate based on shared credit risk characteristics and the days past due. Generally, invoices are due for payment within 90 days from shipment of goods. Loss allowance is calculated using an ageing factor, geographical risk and specific customer knowledge. The allowance is based on a provision matrix on days past due and a forward looking element relating mainly to incorporation of Dun & Bradstreet country risk ratings and an individual assessment. Refer to note 4.4 for a general description of credit risk. Trade receivables 66,564 (1,794) 64,770 2022 Not yet due 1-90 days 91-180 days 50,649 (920) 49,729 729 (113) 616 194 (77) 117 181-270 days 149 (51) 98 271-360 days 57 (57) More than 360 days past due 302 (302) Trade receivables 52,080 (1,520) 50,560 EMEA 9,486 (859) 8,627 China 1,138 1,138 Rest of World 5,297 (632) 4,665 North America Operations 36,159 (29) 36,130 Trade receivables 52,080 (1,520) 50,560
View entire presentation